# The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer

> **NCT04791293** · — · COMPLETED · sponsor: **Istanbul Training and Research Hospital** · enrollment: 159 (actual)

## Conditions studied

- Gastric Cancer
- Complication,Postoperative
- Complications; Gastrointestinal, Postoperative
- Morality

## Interventions

- **OTHER:** MELD-Na score

## Key facts

- **NCT ID:** NCT04791293
- **Lead sponsor:** Istanbul Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2022-08-05
- **Final completion:** 2022-08-05
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791293, "The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04791293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*